REGENERON PHARMACEUTICALS, INC. (REGN) › EPS (Diluted)REGENERON PHARMACEUTICALS, INC. (REGN) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2010: $-1.262011: $-2.452012: $6.752013: $3.722014: $2.982015: $5.522016: $7.702017: $10.342018: $21.292019: $18.462020: $30.522021: $71.972022: $38.222023: $34.772024: $38.342025: $41.48$41.482010EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$41.48+8.2%2024$38.34+10.3%2023$34.77-9.0%2022$38.22-46.9%2021$71.97+135.8%2020$30.52+65.3%2019$18.46-13.3%2018$21.29+105.9%2017$10.34+34.3%2016$7.70+39.5%2015$5.52+85.2%2014$2.98-19.9%2013$3.72-44.9%2012$6.75+375.5%2011$-2.45-94.4%2010$-1.26—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share